Illumina Inc. (NASDAQ:ILMN) stock is trading higher after the company reported better-than-expected third-quarter earnings.

ILMN shares are climbing with conviction. Watch the momentum here

The DNA sequencing company reported adjusted earnings of $1.34 per share, beating the consensus of $1.17.

The company, in its prepared remarks, said the performance reflects the momentum in the clinical markets, where sequencing consumables revenue grew at a high single-digit rate year-over-year.

The sales reached $1.084 billion, beating the consensus of $1.065 billion, flat compared to a year ago, on both a reported and constant currency basis.

Also Read: Illumina Settles With DOJ, Veterans To End Whistleblower Lawsuit

“I am pleased to ...